344 related articles for article (PubMed ID: 11007921)
21. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
[TBL] [Abstract][Full Text] [Related]
22. SHP1 protein tyrosine phosphatase negatively modulates erythroid differentiation and suppression of apoptosis in J2E erythroleukemic cells.
Bittorf T; Seiler J; Zhang Z; Jaster R; Brock J
Biol Chem; 1999 Oct; 380(10):1201-9. PubMed ID: 10595583
[TBL] [Abstract][Full Text] [Related]
23. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis.
Sui X; Krantz SB; You M; Zhao Z
Blood; 1998 Aug; 92(4):1142-9. PubMed ID: 9694701
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2.
Valk P; Verbakel S; von Lindern M; Löwenberg B; Delwel R
Hematol J; 2000; 1(4):254-63. PubMed ID: 11920199
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor induces hypertrophic responses and Stat5 activation in rat ventricular cardiomyocytes.
Rebsamen MC; Arrighi JF; Juge-Aubry CE; Vallotton MB; Lang U
J Mol Cell Cardiol; 2000 Apr; 32(4):599-610. PubMed ID: 10756117
[TBL] [Abstract][Full Text] [Related]
27. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.
Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y
Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467
[TBL] [Abstract][Full Text] [Related]
28. Prolactin induces c-Myc expression and cell survival through activation of Src/Akt pathway in lymphoid cells.
Domínguez-Cáceres MA; García-Martínez JM; Calcabrini A; González L; Porque PG; León J; Martín-Pérez J
Oncogene; 2004 Sep; 23(44):7378-90. PubMed ID: 15286700
[TBL] [Abstract][Full Text] [Related]
29. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway.
Santos SC; Lacronique V; Bouchaert I; Monni R; Bernard O; Gisselbrecht S; Gouilleux F
Oncogene; 2001 Apr; 20(17):2080-90. PubMed ID: 11360192
[TBL] [Abstract][Full Text] [Related]
30. Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor.
Yamamura Y; Senda H; Noda M; Ikawa Y
Leukemia; 1997 Apr; 11 Suppl 3():432-4. PubMed ID: 9209415
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
[TBL] [Abstract][Full Text] [Related]
32. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
[TBL] [Abstract][Full Text] [Related]
34. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats.
Sola A; Rogido M; Lee BH; Genetta T; Wen TC
Pediatr Res; 2005 Apr; 57(4):481-7. PubMed ID: 15718373
[TBL] [Abstract][Full Text] [Related]
35. STAT1 is involved in signal transduction in the EPO induced HEL cells.
Chu J; Gui CY; Fan J; Tang XD; Qiao RL
Cell Res; 1998 Jun; 8(2):105-17. PubMed ID: 9669026
[TBL] [Abstract][Full Text] [Related]
36. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.
Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y
Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823
[TBL] [Abstract][Full Text] [Related]
37. Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor.
Arcasoy MO; Jiang X
Br J Haematol; 2005 Jul; 130(1):121-9. PubMed ID: 15982354
[TBL] [Abstract][Full Text] [Related]
38. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.
Reese TT; Gregory RC; Sharlow ER; Pacifici RE; Crouse JA; Todokoro K; Wojchowski DM
Growth Factors; 1997; 14(2-3):161-76. PubMed ID: 9255607
[TBL] [Abstract][Full Text] [Related]
39. Differential roles of SOCS family members in EpoR signal transduction.
Jegalian AG; Wu H
J Interferon Cytokine Res; 2002 Aug; 22(8):853-60. PubMed ID: 12396724
[TBL] [Abstract][Full Text] [Related]
40. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]